小尺寸WEB装置再治疗率低于大尺寸装置:WorldWideWEB研究结果
本研究基于30家国际中心的回顾性数据,纳入1473例接受WEB治疗的颅内动脉瘤患者,其中229例使用≤4.5 mm小尺寸装置。小尺寸WEB再治疗率低于大尺寸装置(4.3% vs 8.8%),完全闭塞率更高(末次随访76.2% vs 58.5%),功能结局与安全性相似。超大尺寸(>7.5 mm)装置再治疗率最高(16.1%),完全闭塞率最低。
要点
- 小尺寸WEB(≤4.5 mm)再治疗率低于大尺寸装置,完全闭塞率更高。
- 超大尺寸WEB(>7.5 mm)再治疗率最高(16.1%),闭塞率最低。
- 小尺寸与大尺寸WEB的安全性事件(出血、血栓栓塞)无显著差异。
核心结论
- 小尺寸WEB装置(≤4.5 mm)较大尺寸装置再治疗率更低、完全闭塞率更高,功能结局与安全性相当。
- 超大尺寸WEB装置(>7.5 mm)再治疗率最高、完全闭塞率最低,安全性与小尺寸装置相当。
研究设计与样本
- 回顾性多中心研究,来自WorldWideWEB联盟30家国际中心,纳入1473例接受WEB治疗的成人颅内动脉瘤患者。
- 患者按装置尺寸分为小尺寸组(≤4.5 mm,n=229)和大尺寸组(>4.5 mm),另设超大尺寸(>7.5 mm)亚组进行比较。
- 主要结局为再治疗率,次要结局包括改良Rankin量表评分、围手术期及末次随访血管造影结果、出血与血栓栓塞并发症。
关键影像表现/征象
- 小尺寸WEB组围手术期完全闭塞率为57.1%,高于大尺寸组的36.6%(p<0.01)。
- 小尺寸WEB组末次随访完全闭塞率为76.2%,高于大尺寸组的58.5%(p<0.01)。
- 超大尺寸WEB组围手术期完全闭塞率为32.2%,末次随访完全闭塞率为50.5%,均显著低于其他组(p<0.001)。
诊断标准与关键数值
- 小尺寸组再治疗率4.3%,大尺寸组8.8%(p=0.04);超大尺寸组再治疗率16.1%(p<0.001)。
- 小尺寸组颅内出血发生率2.6%,大尺寸组0.9%(p=0.10);血栓栓塞并发症小尺寸组3.1%,大尺寸组3.9%(p=0.69)。
- 两组中位改良Rankin量表评分均为1分(四分位距1-2),组间无显著差异(p=0.88)。
临床应用与阅片要点
- 对于尺寸匹配的颅内动脉瘤,小尺寸WEB装置可作为有效治疗选择,无需因置入技术难度而回避使用。
- 阅片随访时需重点关注超大尺寸WEB装置置入后的复发征象,因其再治疗率可达16.1%。
- 小尺寸WEB术后即刻及随访期完全闭塞率较高,报告闭塞程度时可参考该装置类型对应的预期闭塞水平。
局限性
- 本研究为回顾性设计,存在选择偏倚与信息偏倚的可能。
- 多中心参与在装置选择、置入技术和随访方案上可能缺乏统一标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Small Woven EndoBridge (WEB) devices (≤ 4.5 mm) for the intracranial aneurysm treatment are technically challenging to deploy, with limited efficacy and safety data. This study compared functional, angiographic, and safety outcomes of small WEBs with large (> 4.5 mm) and very large (> 7.5 mm) WEBs.
MATERIALS AND METHODS: The WorldWideWEB consortium is a retrospective, multicenter collaboration across 30 international institutions including adults with intracranial aneurysms treated with WEB. Patients were stratified into small (≤ 4.5 mm) and large (> 4.5 mm) groups; a subanalysis compared small with very large (> 7.5 mm) devices. Primary outcome was retreatment rate. Secondary outcomes included modified Rankin Scale (mRS), angiographic outcomes periprocedurally and last follow-up (FU), and safety events (intracranial hemorrhage (ICH) and thromboembolic complications (TECs)).
RESULTS: Among 1473 patients, 229 (15.5%) received small WEBs. Baseline characteristics were similar. Small WEBs showed lower retreatment (4.3% vs 8.8%, p = 0.04) and higher complete occlusion (periprocedurally: 57.1% vs 36.6%, p < 0.01; FU: 76.2% vs 58.5%, p < 0.01). Median mRS was comparable (1 [1-2] vs 1 [1-2], p = 0.88), as was safety (ICH 2.6% vs 0.9%, p = 0.10; TECs 3.1% vs 3.9%, p = 0.69). Very large WEBs had higher retreatment (16.1%, p < 0.001) and lower complete occlusion (periprocedurally: 32.2%, p < 0.001; FU: 50.5%, p < 0.001), with comparable safety (ICH 0.9%, p = 0.27; TECs 4.5%, p = 0.51).
CONCLUSION: Small WEBs demonstrated lower retreatment, superior anatomic and comparable clinical outcomes compared with large devices, with similar safety profiles.
KEY POINTS: Question Do small Woven EndoBridge devices have comparable efficacy and safety to larger devices for intracranial aneurysm treatment despite technical deployment challenges? Findings Small Woven EndoBridge devices (≤ 4.5 mm) achieved lower retreatment rates and superior angiographic occlusion compared with larger devices, with similar safety and functional outcomes. Clinical relevance These findings support the use of small Woven EndoBridge devices for appropriately sized aneurysms, providing reassurance that deployment challenges do not translate into worse clinical outcomes, while superior anatomic outcomes may encourage their broader adoption in clinical practice.
引用
- Dugar, Salim, Musmar, et al. Smaller WEB devices show lower retreatment rates than larger devices: results from the WorldWideWEB study. Eur Radiol. 2026. PMID: 42711440. doi:10.1007/s00330-026-12840-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。